Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.66 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €345.00 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €41.80 | - | - |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €12.95 | €13.50 | 4.247% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €46.58 | €70.00 | 50.295% |
| Sanofi S.A. ADR | 11 | 1 | 0 | 0 | €44.60 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.00 | €26.58 | 10.756% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.50 | €4.00 | 60.000% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €84.80 | €100.00 | 17.925% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.02 | €13.74 | 1243.324% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.06 | - | - |